
Why Your LIS Is the Most Underrated Revenue System in the Lab Table of Contents TL;DR CrelioHealth LIS is more than a laboratory workflow system
TL;DR
CrelioHealth LIS is more than a laboratory workflow system – it can directly impact lab revenue. From order entry and accessioning to charge capture and coding, errors upstream can lead to missed charges and claim denials. Mapping LIS data with billing and RCM helps labs detect revenue leakage earlier, automate charge capture, reduce manual reconciliation, and give operations and finance a shared source of truth.
A laboratory information system, or LIS, manages the operational path a sample takes through your lab: accessioning, test ordering, results release, and specimen tracking. Every one of those steps also triggers a financial event. A charge. A billing code. A claim input. That happens whether anyone downstream is watching for it or not.
That second half is the part your finance team usually misses. Your LIS was built and bought as an operations tool. Most teams judge it on TAT, throughput, and interface count alone. But look at what it actually generates over the course of a single shift:
Finance rarely owns this system today, and that blind spot is expensive because it is invisible. Nobody audits your LIS for revenue impact the way they audit a claims scrubber. On paper, it does not look like a financial system. It behaves like one anyway, on every order your lab processes.
Here is the mechanism in one line: a missed charge-capture trigger at accessioning cascades into a denied claim weeks later. By the time your billing team sees the denial, nothing about it points back to where the problem started.
That is what makes lab revenue leakage so hard to catch. It never shows up as a line item on a dashboard. It shows up as a denial rate that looks like a billing problem. In reality, the defect started upstream, days or weeks earlier, in a system where nobody was watching for exactly this.
Run the numbers for a mid-sized lab processing 3,000 billable orders per month. Assume a 10% denial rate; the threshold is 41% that providers now report crossing, per Experian Health. Add roughly $25 in staff time to rework each denied claim. That is 300 reworked claims a month. It adds up to $7,500 in staff hours every month, and that number does not even count the cash sitting in limbo while each resubmission clears. None of it shows up on a P&L line called “LIS.” It shows up as billing headcount that never seems quite enough.
This is the exact mechanism behind the five operational levers that protect lab profit margins. The earlier your lab catches an error, the less it costs to fix. Everything downstream of accessioning is just interest accruing on a defect nobody flagged in time.
Three moves do most of the work, and none of them require new software to start:
Shared KPIs may sound like a meeting agenda item, but the effect is concrete. Once ops and finance see the same denial number on the same screen, the conversation changes. It stops being “billing’s problem” and becomes a shared operational metric, which is the only framing that gets it fixed.
A connected LIS revenue cycle management setup exists to close exactly this mechanism. CrelioHealth’s LIS ties into billing at three specific points:
The changes for your billing team are simple. A denial no longer needs a forensic investigation to trace back to its root cause. The accessioning record, the order, and the claim all live in one system, instead of three systems your staff has to reconcile by hand. See how CrelioHealth’s LIS connects to billing on your own test menu and payer mix before deciding whether this is worth the conversation.
Any lab running finances out of spreadsheets hits the same tipping point eventually. It arrives the moment reconciliation starts taking longer than the billing cycle itself. Once that happens, the spreadsheet stops being a safety net. It becomes the bottleneck.
| Criteria | Spreadsheet-based model | LIS-driven model |
|---|---|---|
| Reconciliation timing | Month-end catch-up | Real-time, as claims move |
| Source of truth | Two separate exports, manually matched | One system of record |
| Error detection | After the billing cycle closes | Before the claim goes out |
| Who sees the gap first | Whoever runs the month-end report | Ops and finance, on the same dashboard |
The comparison above is not about spreadsheets being a bad tool in general. It is about what happens when you ask a tool built for static snapshots to track something that changes every hour of every shift
You don’t need a platform overhaul to start closing this gap. A 30 day pilot gets your lab most of the way there:
That last question usually matters the most. A lab that runs this checklist and still cannot close the gap has learned something a spreadsheet never would have told it.
No. An LIS manages the clinical and operational path a sample takes, from accessioning through results release. Billing software manages claims and payer submissions. They are connected systems, not the same system, and the connection between them is exactly where your revenue tends to leak.
Yes, indirectly. A missed order, an accessioning error, or a data gap at intake does not deny a claim on its own. But it feeds bad or incomplete data into coding, and coding errors are one of the most common reasons payers reject claims outright.
It comes down to the data source. LIS-based RCM pulls billing events straight from the same record that tracks the sample, so there is only one system of truth. A standalone billing system runs on a separate data set, and your staff has to reconcile it with the LIS by hand, usually on a lag
Not necessarily right away. If reconciliation still finishes inside the billing cycle and ops and finance agree on the numbers, spreadsheets can hold for now. Once reconciliation starts slipping past the billing cycle, that is the practical signal it is time to move the tracking into your LIS itself.
Subscribe now to keep reading and get access to the full archive.